You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Antibiotic Stewardship: Using Clinical Guidelines to Control Antibiotic Overuse and Deter Microbial Adaptation

Wlodaver, Clifford G. MD*†; May, Christopher PharmD

Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e31822e9bba
Review Articles
Abstract

Abstract: The multidrug-resistant organism and Clostridium difficile epidemics, which are adverse consequences of antibiotic use, continue to grow. Antibiotic stewardship—a program aimed at the judicious use of antibiotics—is a deterrent. Yet, its implementation, whether through prospective audit with intervention and feedback or by formulary restriction and preauthorization, experiences the underuse of clinical guidelines for when antibiotics should be withheld and withdrawn. This article is the first to catalog and summarize the guidelines for controlling antibiotic overuse to facilitate their implementation. Conditions for which antibiotics are not justified include nonbacterial respiratory syndromes, asymptomatic bacteriuria, colonization and culture contamination, selected cases of acute otitis media and skin and soft tissue infections, and “low-grade” fever. Traditionally accepted durations should be shortened for acute exacerbations of chronic bronchitis, pneumonias, urinary tract infections, intra-abdominal infections, Staphylococcus aureus bacteremia, and surgical prophylaxis. Studies demonstrate that guideline implementation through antibiotic stewardship can enhance outcomes and decrease resistance. Unfamiliarity with the guidelines should be addressed by their more widespread dissemination. Their imperfections should be addressed by more placebo-controlled trials. Concerns of undertreatment need to be counterbalanced by the adverse consequences of overtreatment. We believe that regulatory agencies should consider promoting antibiotic stewardship.

Author Information

From the *Midwest Regional Medical Center, Midwest City; †College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City; and ‡Department of Pharmacy, Midwest Regional Medical Center, Midwest City, OK.

Correspondence to: Clifford G. Wlodaver, MD, 8121 National Ave, Suite 310, Midwest City, OK 73110. E-mail: cliff_wlodaver@yahoo.com.

The authors have no funding or conflicts of interest to disclose.

© 2012 Lippincott Williams & Wilkins, Inc.